Disparities in frontline treatment and overall survival in the era of targeted tyrosine kinase inhibitor therapy for chronic myeloid leukemia: 2004-2021.

被引:0
|
作者
Vardell, Victoria
Tantravahi, Srinivas Kiran
机构
[1] Univ Utah, Dept Hematol & Hematol Malignancies, Salt Lake City, UT USA
[2] Univ Utah, Huntsman Canc Inst, Div Hematol & Hematol Malignancies, Salt Lake City, UT USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
11187
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Trends in Frontline Treatment and Overall Survival in the Era of Targeted Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia
    Vardell, Victoria A.
    Sobieski, Catherine E.
    Tantravahi, Srinivas K.
    BLOOD, 2022, 140 : 6763 - 6764
  • [2] Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era: What Is the "Best" Therapy?
    Agrawal, Meetu
    Garg, Ravin J.
    Kantarjian, Hagop
    Cortes, Jorge
    CURRENT ONCOLOGY REPORTS, 2010, 12 (05) : 302 - 313
  • [3] Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era: What Is the “Best” Therapy?
    Meetu Agrawal
    Ravin J. Garg
    Hagop Kantarjian
    Jorge Cortes
    Current Oncology Reports, 2010, 12 : 302 - 313
  • [4] Chronic myeloid leukemia in the tyrosine kinase inhibitor era: What is the best therapy?
    Alfonso Quintás-Cardama
    Jorge Cortes
    Current Oncology Reports, 2009, 11 : 337 - 345
  • [5] Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era: What Is the Best Therapy?
    Quintas-Cardama, Alfonso
    Cortes, Jorge
    CURRENT ONCOLOGY REPORTS, 2009, 11 (05) : 337 - 345
  • [6] Treatment of Chronic Myeloid Leukemia Elderly Patients in the Tyrosine Kinase Inhibitor Era
    Russo, Domenico
    Malagola, Michele
    Skert, Cristina
    Fili, Carla
    Bergonzi, Cesare
    Cancelli, Valeria
    Cattina, Federica
    CURRENT CANCER DRUG TARGETS, 2013, 13 (07) : 755 - 767
  • [7] Second Malignancies Following Treatment of Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era
    Gunnarsson, Niklas
    Leif, Stenke
    Hoglund, Martin
    Sandin, Fredrik
    Bjorkholm, Magnus
    Dreimane, Arta
    Lambe, Mats
    Markevarn, Berit
    Olsson-Stromberg, Ulla
    Richter, Johan
    Wadenvik, Hans
    Wallvik, Jonas
    Sjalander, Anders
    BLOOD, 2014, 124 (21)
  • [8] Monocytic Crisis of Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitor
    Tsunemine, Hiroko
    Arima, Hiroshi
    Itoh, Kiminari
    Sakane, Emiko Ishikawa
    Akasaka, Hiroshi
    Kodaka, Taiichi
    Takahashi, Takayuki
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2013, 53 (03) : 227 - 233
  • [9] Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: An Evolving Paradigm of Molecularly Targeted Therapy
    Mohamed A. M. Ali
    Molecular Diagnosis & Therapy, 2016, 20 : 315 - 333
  • [10] Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: An Evolving Paradigm of Molecularly Targeted Therapy
    Ali, Mohamed A. M.
    MOLECULAR DIAGNOSIS & THERAPY, 2016, 20 (04) : 315 - 333